Jennifer R Deem, NP
Nurse Practitioner · San Mateo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
Offices
1 location · One Medical Group Inc · 330 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Jennifer R Deem’s office at (888) 663-6331 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Medicaid work
$3,403 in 2021
Medicaid paid $3,403 for 172 billed services this clinician did in 2021, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SARSCOV CORONAVIRUS AG IA | 108 | $2,561 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 12 | $437 |
| OFF/OP EST MAY X REQ PHY/QHP | 52 | $404 |
| 2021 | 172 | 3 | 23 | $3,403 |
| 2020 | 18 | 1 | 18 | $200 |
See the largest Medicaid services in earlier years
2020
| OFF/OP EST MAY X REQ PHY/QHP | 18 | $200 |
Drugs they prescribed that Part D paid
$52,241
Pharmacies billed $52,241 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (23 of 1,219) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
1,130 generic and fewer than 11 brand-name prescriptions · $52,241 in drug cost · 22 antibiotic prescriptions to 19 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 12 | $10,112 | $843 |
| Atorvastatin | 132 | $1,123 | $9 |
| Pregabalin | 11 | $857 | $78 |
| Telmisartan | 39 | $832 | $21 |
| Levothyroxine | 49 | $696 | $14 |
See all 27 drugs
| Eliquis | 12 | $10,112 | $843 |
| Atorvastatin | 132 | $1,123 | $9 |
| Pregabalin | 11 | $857 | $78 |
| Telmisartan | 39 | $832 | $21 |
| Levothyroxine | 49 | $696 | $14 |
| Synthroid | 13 | $424 | $33 |
| Amlodipine Besylate | 101 | $420 | $4 |
| Metoprolol | 33 | $391 | $12 |
| Losartan | 60 | $343 | $6 |
| Pantoprazole | 26 | $325 | $12 |
| Lisinopril | 46 | $310 | $7 |
| Hydrocodone-Acetaminophen | 13 | $293 | $23 |
| Gabapentin | 18 | $252 | $14 |
| Rosuvastatin | 18 | $226 | $13 |
| Montelukast | 11 | $181 | $16 |
| Metformin | 40 | $164 | $4 |
| Zolpidem | 24 | $124 | $5 |
| Hydrochlorothiazide | 20 | $124 | $6 |
| Sumatriptan | 12 | $107 | $9 |
| Alendronate | 15 | $101 | $7 |
| Spironolactone | 12 | $84 | $7 |
| Simvastatin | 15 | $79 | $5 |
| Atenolol | 11 | $76 | $7 |
| Lovastatin | 11 | $59 | $5 |
| Clonazepam | 16 | $49 | $3 |
| Trazodone | 18 | $47 | $3 |
| Tamsulosin | 15 | $17 | $1 |
Year by year
| 2024 | 1,219 | 203 | 2% (23) | None | $52,241 |
| 2023 | 821 | 153 | 2% (18) | 10% | $44,152 |
| 2022 | 715 | 143 | 3% (19) | 9% | $65,962 |
| 2021 | 86 | 42 | None | None | $4,301 |
| 2020 | 18 | None | 0% (0) | None | $156 |
| 2019 | 26 | 24 | 0% (0) | None | $823 |
| 2018 | 29 | 22 | 0% (0) | None | $850 |
| 2017 | 12 | None | 0% (0) | None | $131 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Jardiance | 17 | $10,828 | $637 |
| Telmisartan | 27 | $1,937 | $72 |
| Atorvastatin | 62 | $740 | $12 |
| Rosuvastatin | 17 | $675 | $40 |
| Synthroid | 13 | $590 | $45 |
| Levothyroxine | 42 | $586 | $14 |
| Amlodipine Besylate | 69 | $546 | $8 |
| Losartan | 41 | $389 | $9 |
| Lisinopril | 31 | $351 | $11 |
| Metoprolol | 15 | $300 | $20 |
| Pantoprazole | 21 | $298 | $14 |
| Sumatriptan | 12 | $283 | $24 |
| Hydrocodone-Acetaminophen | 11 | $214 | $19 |
| Hydrochlorothiazide | 24 | $177 | $7 |
| Metformin | 24 | $173 | $7 |
| Zolpidem | 19 | $158 | $8 |
| Alendronate | 12 | $136 | $11 |
| Tamsulosin | 14 | $130 | $9 |
| Lovastatin | 11 | $95 | $9 |
| Metoprolol | 11 | $86 | $8 |
| Lorazepam | 18 | $76 | $4 |
| Clomipramine | 12 | $67 | $6 |
2022: 19 drugs
| Fluoxetine | 19 | $1,436 | $76 |
| Telmisartan | 18 | $1,259 | $70 |
| Rosuvastatin | 18 | $1,026 | $57 |
| Levothyroxine | 23 | $593 | $26 |
| Losartan | 34 | $413 | $12 |
| Atorvastatin | 35 | $402 | $11 |
| Amlodipine Besylate | 52 | $399 | $8 |
| Metoprolol | 11 | $308 | $28 |
| Gabapentin | 11 | $191 | $17 |
| Metformin | 22 | $191 | $9 |
| Lisinopril | 38 | $190 | $5 |
| Hydrocodone-Acetaminophen | 14 | $169 | $12 |
| Hydrochlorothiazide | 25 | $150 | $6 |
| Zolpidem | 22 | $146 | $7 |
| Atenolol | 11 | $145 | $13 |
| Glipizide | 11 | $133 | $12 |
| Metformin Hcl Er | 13 | $116 | $9 |
| Tamsulosin | 12 | $80 | $7 |
| Lorazepam | 19 | $58 | $3 |
Money from drug and device companies
$343 in 2025
| 2025 | 3 | 3 | None | $343 |
| 2024 | 7 | 8 | None | $371 |
| 2023 | 7 | 7 | None | $666 |
| 2022 | 3 | 4 | None | $490 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Argenx US | Vyvgart | $122 | 1 payment
|
| Amarin Pharma | Vascepa | $118 | 1 payment
|
| Corcept Therapeutics | Korlym | $103 | 1 payment
|
See all 3 published payments
| Argenx US | Meals · 2025-05-14 | Vyvgart | $122 |
| Amarin Pharma | Meals · 2025-03-14 | Vascepa | $118 |
| Corcept Therapeutics | Meals · 2025-01-08 | Korlym | $103 |
See earlier years (2024, 2023, 2022)
2024: $371
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $168 | 1 payment
|
| Evofem Biosciences | None | $78 | 1 payment
|
| Hologic Sales and Service | Aptima | $43 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $24 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $23 | 1 payment
|
| Currax Pharmaceuticals | Contrave | $17 | 1 payment
|
| Lilly USA | Mounjaro | $17 | 1 payment
|
2023: $666
| Abbvie | Vraylar | $130 | 1 payment
|
| Averitas Pharma | Qutenza | $130 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $128 | 1 payment
|
| Iti | Caplyta | $126 | 1 payment
|
| Sage Therapeutics | None | $111 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $21 | 1 payment
|
| Hologic Sales and Service | Aptima | $19 | 1 payment
|
2022: $490
| Amgen | Repatha | $260 | 2 payments
|
| PharmaEssentia USA | Besremi | $125 | 1 payment
|
| Abbvie | Vraylar | $105 | 1 payment
|
Professional record
- NPI
- 1922455971
- Licence
- CA 685008, CA 95004000
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X); Federal specialty code 163W00000X (163W00000X); Nurse practitioner (363L00000X)
- Mailing address
- 1 Embarcadero Ctr Ste 1900, San Francisco, CA, 94111
- NPI first listed
- 2016-05-19
- NPI last updated
- 2025-03-17
- NPI record certified
- 2025-03-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2700 Homestead Rd, Santa Clara, CA, 95051